Aldeyra Therapeutics, Inc. (ALDX) income statement
ALDXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.84+0.12 (+16.39%)
Close on Nov 20, 2026Market cap $50.67MP/E –Yield –
Aldeyra Therapeutics, Inc. financial ratios
See a number that looks wrong?